Ravi Ananthanarayanan, Livemint

Ravi Ananthanarayanan


Contact Ravi

Discover and connect with journalists and influencers around the world, save time on email research, monitor the news, and more.

Start free trial

  • Unknown
  • Livemint

Past articles by Ravi:

FMCG stocks back in favour as costs beat a retreat

The BSE FMCG index is still down by 9.3% since end-August, but is up by that same rate over its lows of early-October → Read More

Smaller FMCG firms race ahead, put bigger rivals on notice

The rapid growth in revenue of local and regional FMCG companies can throw up a few risks for their national peers → Read More

Q2 results: Hindalco’s domestic outlook hinges on foreign actors

How Hindalco does from here will depend more on external factors such as China’s economic strength and a patch-up on the trade war front → Read More

Marico Q2 results: Getting off the inflation tiger

Rising costs of copra have been singeing Marico’s profit margins in earlier quarters. Now that they are declining, margins should improve. But it’s not that simple → Read More

Lupin’s Q2 results offers hope of a revival

Lupin’s sales growth stabilized in the September quarter but margins are stuck in a rut → Read More

The message for the Horlicks maker in the Complan deal

Horlicks maker GSK Consumer’s sales growth has slowed down and it also faces similar market challenges as former Complan maker Heinz India → Read More

Hindustan Zinc dividend payout offsets dull Q2 results

Hindustan Zinc shareholders must be holding on to hope that the dip in the performance in the September quarter is temporary → Read More

India’s rising steel demand is making companies starry-eyed

World Steel Association, a global industry body, released its short-range demand outlook this week, saying what was already known that India’s growth ranks highest among major steel-consuming countries, but the gap is widening sharply → Read More

HUL Q2: Rising input costs face off against healthy demand growth

While HUL sales rose by 11.5% in Q2, its costs increased by 12.9% over a year ago, reflecting the creeping effect of inflation in crude oil-based inputs and rupee fall → Read More

HUL Q2 signals pick-up in consumer demand

Hindustan Unilever Ltd’s (HUL) double-digit growth has exceeded estimates, and going forward, the demand outlook remains healthy → Read More

Demand remains a bright spot for steel companies in second quarter

While India’s steel industry seems to be in good shape, the chief risk it faces is external → Read More

Sweeping price hikes may invite backlash for FMCG companies

If consumers feel the pinch and politicians stir the pot, the government could turn the screws on the FMCG sector → Read More

In Aurobindo Pharma’s US acquisition, beauty runs skin deep

Aurobindo is acquiring the dermatology business which contributes to 30% of the acquired business’s revenues, with the remaining contributed by the oral solids business → Read More

Are high FMCG valuations about to get in touch with reality?

While the sales growth situation looks promising for companies, this needs to trickle down to higher profit growth. About half of most FMCG companies’ sales go towards meeting input costs → Read More

Nestle India: Noodles good, coffee better in first half of 2018

As growth in Maggi noodles comes to more normal levels, Nestle India needs other categories to step up—the confectionery segment has done so in the first half → Read More

Why Trump need not worry about quarterly reporting of earnings

Quarterly earnings reporting ensures more information symmetry among institutional and individual investors → Read More

Why auditors are under scrutiny from regulators and investors, globally

One of the main issues concerns the separation of the audit and consulting work that the top firms offer to the same companies → Read More

Fortis Healthcare: What now, after IHH entry and June quarter loss?

Only time will tell whether it will be business as usual, or IHH Healthcare will make significant changes in how the Fortis hospitals are run and its expansion plans → Read More

Mayday, Mayday: Auditors on high alert

The regulatory glare on auditors is increasing. The ripple effects are being felt across the Indian business ecosystem → Read More

Q1 results: Sun Pharma’s US business peeps out from clouds

What is surprising is that despite the increase in sales in the US, Sun Pharma’s gross margins have declined both from a year earlier and sequentially → Read More